Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial-Reference-Cited by-同舟云学术

Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

Published:2022-10-15 Issue:6 Volume:11 Page:2205-2217
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Sinha Sanjeev,Ajayababu Anuj,Thukral Himanshu,Gupta Sushil,Guha Subhasish Kamal,Basu Ayan,Gupta Gaurav,Thakur Prashant,Lingaiah Raghavendra,Das Bimal Kumar,Singh Urvashi B.,Singh Ravinder,Narang Rajiv,Bhowmik Dipankar,Wig Naveet,Modak Dolan Champa,Bandyopadhyay Bhaswati,Chakrabarty Banya,Kapoor Aditya,Tewari Satyendra,Prasad Narayan,Hashim Zia,Nath Alok,Kumari Niraj,Goswami Ravinder,Pandey Shivam,Pandey Ravindra Mohan

Funder

Indian Council of Medical Research

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-022-00703-y.pdf

Reference24 articles.

1. WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. https://covid19.who.int/table.

2. Benn CS, Netea MG, Selin LK, Aaby P. A small jab—a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013;34(9):431–9. https://doi.org/10.1016/j.it.2013.04.004 (Epub 2013 May 14; PMID: 23680130).

3. Garly ML, Martins CL, Balé C, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A nonspecific beneficial effect of BCG? Vaccine. 2003;21(21–22):2782–90. https://doi.org/10.1016/s0264-410x(03)00181-6 (PMID: 12798618).